Online support for people with differentiated thyroid cancer after radioactive iodine treatment
The development of a technology-based information support intervention (iSupport) among patients with differentiated thyroid cancer post radioactive iodine therapy
['FUNDING_OTHER'] · GEORGETOWN UNIVERSITY · NIH-11311315
A web-based program to help people with differentiated thyroid cancer manage side effects and improve quality of life after radioactive iodine treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGETOWN UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11311315 on ClinicalTrials.gov |
What this research studies
You would use a web-based program called RAI Support that provides education, symptom-management tools, and emotional support after radioactive iodine (RAI) therapy. The research team will run a small randomized trial with about 88 participants where some people use RAI Support and others receive usual care. The study will check whether people find the program usable and acceptable and whether it helps quality of life, symptom burden, knowledge, confidence in managing symptoms, and cancer-related distress. The project is led by researchers at Georgetown University and runs through 2028.
Who could benefit from this research
Good fit: People diagnosed with differentiated thyroid cancer who have completed radioactive iodine therapy and can access an online program are the ideal candidates.
Not a fit: People who have not received RAI, who cannot use web-based tools, or who require immediate medical care for complications may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this program could reduce symptom burden and improve quality of life for thyroid cancer survivors after RAI.
How similar studies have performed: Web-based survivorship and symptom-management programs have helped other cancer survivor groups, but applying this approach specifically to thyroid cancer after RAI is relatively new.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGETOWN UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CARR, ALAINA L — GEORGETOWN UNIVERSITY
- Study coordinator: CARR, ALAINA L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.